Our Services
Medical Information
Helpful Resources
Published on: 9/23/2026
RSV spreads when an infected person coughs or sneezes and you breathe in their respiratory droplets, when those droplets land in your eyes, nose, or mouth, or when you touch a contaminated surface like a doorknob, crib rail, or toy and then touch your face; direct contact, such as kissing a child's face, also passes it along. The virus survives for hours on hard surfaces and spreads most easily in crowded, close-contact settings including homes, daycares, schools, nursing homes, and hospitals, with most U.S. cases occurring during fall and winter. People are typically contagious for 3 to 8 days, though infants and those with weakened immune systems can spread it for up to four weeks, even without symptoms. Several factors affect your risk and how serious an infection may become, so see below to understand more.
Because RSV can look like a common cold in adults but turn dangerous quickly in infants and older adults, knowing whether your symptoms warrant a call to a doctor matters, and a free, instant online symptom check can help you sort out what is likely going on and what step to take next.
Last reviewed for medical accuracy: 09/23/2026
Respiratory syncytial virus (RSV) is a common virus that infects the lungs and breathing passages. Most people encounter RSV by age two, and for many, it feels like a mild cold. However, RSV can cause more severe illness—especially in infants, older adults, and those with weakened immune systems.
Understanding how do you get RSV helps you take steps to protect yourself and loved ones. RSV spreads very easily. Key transmission routes include:
Once RSV enters your body, it travels through the respiratory tract:
People at higher risk for severe spread include:
RSV symptoms usually appear 4–6 days after exposure. They often start mild but can worsen, especially in high-risk groups.
Common symptoms:
Symptoms that suggest lower respiratory involvement:
If you’re wondering how do you get RSV and what it looks like, remember that most cases resemble a routine cold. However, watch for warning signs in infants and older adults.
RSV’s ability to spread quickly is due to several factors:
While it’s hard to eliminate RSV risk entirely, you can reduce your chances by following these steps:
Vaccines and monoclonal antibodies are under development or available in some places for high-risk groups. Talk to your doctor about the latest recommendations.
Most healthy people recover at home in 1–2 weeks. Home care focuses on symptom relief:
Certain signs mean RSV may be more serious and need prompt medical attention:
If you or your child develop any of these symptoms, do not hesitate to get help.
For less urgent concerns, you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you decide if you need to speak with a healthcare professional.
If you suspect severe RSV infection or experience any life-threatening or serious symptoms, speak to a doctor right away. Early evaluation and treatment can make a big difference in recovery.
(References)
* Griffiths C, Drews SJ, Marchant DJ. Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment. Clin Microbiol Rev. 2017 Jan;30(1):277-319. doi: 10.1128/CMR.00010-16. PMID: 27903593; PMCID: PMC5217795.
* Binns E, Tuckerman J, Licciardi PV, Wurzel D. Respiratory syncytial virus, recurrent wheeze and asthma: A narrative review of pathophysiology, prevention and future directions. J Paediatr Child Health. 2022 Oct;58(10):1741-1746. doi: 10.1111/jpc.16197. Epub 2022 Sep 8. PMID: 36073299; PMCID: PMC9826513.
* Oppenlander KE, Chung AA, Clabaugh D. Respiratory Syncytial Virus Bronchiolitis: Rapid Evidence Review. Am Fam Physician. 2023 Jul;108(1):52-57. PMID: 37440737.
* Langedijk AC, Vrancken B, Lebbink RJ, Wilkins D, Kelly EJ, Baraldi E, Mascareñas de Los Santos AH, Danilenko DM, Choi EH, Palomino MA, Chi H, Keller C, Cohen R, Papenburg J, Pernica J, Greenough A, Richmond P, Martinón-Torres F, Heikkinen T, Stein RT, Hosoya M, Nunes MC, Verwey C, Evers A, Kragten-Tabatabaie L, Suchard MA, Kosakovsky Pond SL, Poletto C, Colizza V, Lemey P, Bont LJ, INFORM-RSV Study Group. The genomic evolutionary dynamics and global circulation patterns of respiratory syncytial virus. Nat Commun. 2024 Apr 10;15(1):3083. doi: 10.1038/s41467-024-47118-6. Epub 2024 Apr 10. PMID: 38600104; PMCID: PMC11006891.
* Guo L, Deng S, Sun S, Wang X, Li Y. Respiratory syncytial virus seasonality, transmission zones, and implications for seasonal prevention strategy in China: a systematic analysis. Lancet Glob Health. 2024 Jun;12(6):e1005-e1016. doi: 10.1016/S2214-109X(24)00090-1. Epub 2024 Apr 23. PMID: 38670132.
* Mitsi E, Nikolaou E, Goncalves A, Blizard A, Hill H, Farrar M, Hyder-Wright A, Akeju O, Hamilton J, Howard A, Elterish F, Solorzano C, Robinson R, Reiné J, Collins AM, Gordon SB, Moxon RE, Weiser JN, Bogaert D, Ferreira DM. RSV and rhinovirus increase pneumococcal carriage acquisition and density, whereas nasal inflammation is associated with bacterial shedding. Cell Host Microbe. 2024 Sep 11;32(9):1608-1620.e4. doi: 10.1016/j.chom.2024.07.024. Epub 2024 Aug 23. PMID: 39181126.
* Mazur NI, Caballero MT, Nunes MC. Severe respiratory syncytial virus infection in children: burden, management, and emerging therapies. Lancet. 2024 Sep 21;404(10458):1143-1156. doi: 10.1016/S0140-6736(24)01716-1. Epub 2024 Sep 9. PMID: 39265587.
* Wildenbeest JG, Lowe DM, Standing JF, Butler CC. Respiratory syncytial virus infections in adults: a narrative review. Lancet Respir Med. 2024 Oct;12(10):822-836. doi: 10.1016/S2213-2600(24)00255-8. Epub 2024 Sep 9. PMID: 39265602.
* Pickles RJ, Chen G, Randell SH. Enhanced susceptibility of pediatric airway epithelium to respiratory syncytial virus infection. J Clin Invest. 2024 Nov 1;134(21). doi: 10.1172/JCI185689. Epub 2024 Nov 1. PMID: 39484717; PMCID: PMC11527439.
* Foley DA, Smith DW, Barr I, Moore HC, Nicol M, Blyth CC. Determinants of respiratory syncytial virus and human metapneumovirus transmission. Clin Microbiol Rev. 2025 Sep 11;38(3):e0020324. doi: 10.1128/cmr.00203-24. Epub 2025 Aug 1. PMID: 40748057; PMCID: PMC12424386.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.